NVIDIA's Quantum Ambitions and Eli Lilly's Market Setbacks

This chapter highlights NVIDIA's focus on quantum computing at its GTC conference, while reflecting on the CEO's insights into AI advancements. It also examines the stock market's response to Eli Lilly's disappointing sales of weight loss drugs and discusses the FDA's upcoming ban on the food coloring red number three due to cancer concerns.